Feasibility and safety of laparoscopic surgery for metachronous colorectal cancer

Surg Today. 2015 Apr;45(4):434-8. doi: 10.1007/s00595-014-0925-1. Epub 2014 May 20.

Abstract

Purpose: This study assessed the feasibility and safety of laparoscopic surgery for metachronous colorectal cancer in patients who had previously undergone surgery for primary colorectal cancer.

Methods: Of the 52 patients who underwent curative resection for metachronous colorectal cancer from August 2004 to April 2013, 26 each underwent laparoscopic and open surgery. Their clinical characteristics and surgical and postoperative outcomes were compared.

Results: The percentage of patients who underwent previous open surgery was significantly higher in the open group than in the laparoscopic group (92.3 vs. 65.4 %). The body mass index was higher in the laparoscopic group than in the open group (23.8 vs. 21.1 kg/m(2)), and the amount of blood loss was significantly smaller in the laparoscopic than in the open group (30 vs. 195 ml); however, the mean operative time did not differ significantly. The time to first flatus (1 vs. 3 days) and first stool (2 vs. 3.5 days), as well as the length of postoperative hospital stay (10 vs. 16 days), was significantly shorter in the laparoscopic group than in the open group, although the rates of postoperative complications did not differ (15.4 vs. 23.1 %).

Conclusions: Laparoscopic surgery for metachronous colorectal cancer shows short-term benefits compared with open surgery and should be considered as a treatment option in these patients.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Colorectal Neoplasms / surgery*
  • Feasibility Studies
  • Female
  • Genes, Synthetic
  • Humans
  • Laparoscopy*
  • Male
  • Middle Aged
  • Neoplasms, Second Primary / surgery*
  • Recombinant Proteins
  • Retrospective Studies
  • Safety*
  • Treatment Outcome
  • Young Adult

Substances

  • Recombinant Proteins
  • TBI protein, recombinant